Physician profile
Lisa Connelly
NPI 1710428461
$373.62
in general payments reported to CMS, 2019-2025
12 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $256 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $373.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $83.35 | 2024-2025 | Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $70.17 | 2024-2025 | |
| Lilly USA, LLC | $43.98 | 2024-2025 | Zepbound, Mounjaro |
| Abbvie INC. | $30.02 | 2024 | |
| Glaxosmithkline, LLC. | $23.16 | 2024 | Trelegy Ellipta, Arexvy |
| Verona Pharma, INC. | $22.93 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $22.76 | 2024 | Gardasil 9, Capvaxive, Gardasil |
| Boston Scientific Corporation | $16.38 | 2025 | Watchman Access System |
| Exact Sciences Corporation | $16.36 | 2025 | Cologuard Collection Kit |
| Ardelyx, INC. | $15.60 | 2024 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.23 | 2024 | Xifaxan |
| Amgen INC. | $13.68 | 2024 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Connelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.